Skip to main content
Affiliate disclosureWe earn a commission if you buy through links on this page, at no extra cost to you. Read our methodology →
HerbClinical dose · 240mg/day of standardised extract EGb 761 in the positive trials (120mg/day appears under-dosed)Onset · Positive dementia trials ran 22–26 weeks; the Cochrane review assessed outcomes at 6 months

Ginkgo Biloba

The NIH-funded GEM trial (DeKosky 2008, n=3,069, 240mg/day, median 6.1 years) found no reduction in dementia or Alzheimer's incidence in people aged 75+. For existing cognitive impairment and dementia, a meta-analysis of 9 RCTs (Tan et al., 2015, 22–26 weeks, mainly 240mg/day EGb 761) found benefits on cognition and daily living, concentrated in patients with neuropsychiatric symptoms. The 2026 Cochrane review of 82 RCTs found small-to-moderate benefits in dementia (low-certainty evidence) but little or no effect in mild cognitive impairment. A 2013 review rated the dementia evidence low quality, noting most trials were pharmaceutical-industry sponsored. Ginkgo raises bleeding risk with warfarin.

By The Nootropic Lab editorial teamUpdated 8 min read✓ Fact-checked

Evidence reviewed:

Mechanism of action

Ginkgo Biloba extract (standardised to 24% ginkgo flavone glycosides and 6% terpene lactones) works primarily by improving cerebral blood flow through vasodilation and platelet-activating factor (PAF) inhibition. The terpene lactones (ginkgolides A, B, C and bilobalide) reduce blood viscosity and improve microcirculation in brain capillaries. Additionally, ginkgo has antioxidant properties that protect neuronal membranes from lipid peroxidation.

Clinical evidence summary

The NIH-funded GEM trial (DeKosky 2008, n=3,069, 240mg/day, median 6.1 years) found no reduction in dementia or Alzheimer's incidence in people aged 75+. For existing cognitive impairment and dementia, a meta-analysis of 9 RCTs (Tan et al., 2015, 22–26 weeks, mainly 240mg/day EGb 761) found benefits on cognition and daily living, concentrated in patients with neuropsychiatric symptoms. The 2026 Cochrane review of 82 RCTs found small-to-moderate benefits in dementia (low-certainty evidence) but little or no effect in mild cognitive impairment. A 2013 review rated the dementia evidence low quality, noting most trials were pharmaceutical-industry sponsored. Ginkgo raises bleeding risk with warfarin.

Human effect matrix

Based on human clinical trials only. Animal and in-vitro data excluded.

EffectEvidenceMagnitudeStudies
Cerebral Blood Flow strong
Moderate
—
Memory (Cognitive Decline) moderate
Moderate
3
Memory (Healthy Adults) mixed
Small
—
Dementia Prevention strong
Negligible
1

Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results

Documented benefits

  • Cognition and daily living in dementia (low-certainty evidence)
  • Improved cerebral blood flow (not re-verified in our 2026 review)
  • Antioxidant activity

Side effects & cautions

  • Headache
  • GI discomfort
  • Increased bleeding risk with blood thinners: in a large Veterans Administration cohort, ginkgo plus warfarin raised bleeding risk (HR 1.38), and a systematic review links ginkgo to major bleeds including intracranial bleeding — avoid with anticoagulants
  • Rare: allergic skin reactions

How to take

Dosage240mg/day of standardised extract (24/6) — the dose used in the positive trials; lower doses (120mg/day) appear under-dosed
TimingSplit into 2 doses (morning and afternoon) for sustained blood flow effects.
With foodTake with meals to reduce GI discomfort. Absorption is not significantly affected by food.
FormsAlways use standardised extract (24% flavone glycosides, 6% terpene lactones). EGb 761 is the gold-standard pharmaceutical-grade extract used in most clinical trials. Avoid raw leaf or unstandardised products.

Stacking recommendations

Ingredients that pair well with Ginkgo Biloba and why.

Phosphatidylserine

Ginkgo improves blood delivery while PS supports membrane function — complementary pathways for age-related cognitive support.

Lion's Mane

Ginkgo provides acute blood flow support; Lion's Mane builds long-term neuroprotection via NGF. Addresses both immediate and structural brain health.

Bacopa Monnieri

Both have long-term memory benefits via different mechanisms. Ginkgo via blood flow; Bacopa via synaptic density. Combined for comprehensive memory support in older adults.

Frequently asked questions

Does Ginkgo Biloba actually work for healthy young adults?

The evidence is mixed. The clearest benefits are in people with dementia, and the 2026 Cochrane review found little or no effect even in mild cognitive impairment. In healthy young adults, effects on memory and attention are inconsistent across trials. If you are under 40 and cognitively healthy, L-theanine + caffeine has stronger acute evidence.

What is EGb 761 and why does it matter?

EGb 761 is a specific pharmaceutical-grade Ginkgo biloba extract manufactured by Dr. Willmar Schwabe Pharmaceuticals. It is standardised to 24% ginkgo flavone glycosides and 6% terpene lactones, with toxic ginkgolic acid removed below 5ppm. It is the extract used in most of the dementia trials. Generic ginkgo products may not match the potency or purity.

Can I take Ginkgo with blood thinners?

Avoid it unless your doctor agrees. In a large Veterans Administration cohort, taking ginkgo with warfarin raised bleeding risk by 38% (HR 1.38), and a systematic review of warfarin interactions links ginkgo to major bleeding events, including intracranial bleeding. The interaction is clinically documented and potentially serious.

How long before I see results?

The positive dementia trials ran 22–26 weeks at 240mg/day, and the Cochrane review assessed outcomes at 6 months. Do not judge efficacy at 1–2 weeks.

Top stacks containing Ginkgo Biloba

NatureBell Ginkgo + Ginseng

7/10

NatureBell

Ginkgo Biloba in Southeast Asia

Products in Southeast Asia

HSA / NPRA / BPOM / FDA PH / Thai FDA

SEA country guides

Regulatory note

Health supplements in Singapore are regulated by the Health Sciences Authority (HSA); in Malaysia by the National Pharmaceutical Regulatory Agency (NPRA); in Indonesia by the Badan Pengawas Obat dan Makanan (BPOM); in the Philippines by FDA Philippines; in Thailand by FDA Thailand. Halal certification is required by law for supplements marketed to Indonesian consumers from 18 October 2026, regulated by the Badan Penyelenggara Jaminan Produk Halal (BPJPH); in Malaysia, products described as halal must be certified, with the Jabatan Kemajuan Islam Malaysia (JAKIM) as the certifying body. We surface certification status per product where verifiable. This page is editorial, not medical advice. Consult a qualified healthcare professional before starting any supplement.

Sources (6)expand
← Back to Ingredients Guide